Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Over the last 12 months, insiders at Korro Bio, Inc. have bought $10M and sold $855,527 worth of Korro Bio, Inc. stock.
On average, over the past 5 years, insiders at Korro Bio, Inc. have bought $10M and sold $855,527 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SANDELL SCOTT D (10 percent owner) — $26M. BASKETT FOREST (10 percent owner) — $22M. Florence Anthony A. Jr. (10 percent owner) — $16M.
The last purchase of 17,857 shares for transaction amount of $999,992 was made by Yang Rick (10 percent owner) on 2024‑04‑22.
2024-11-11 | Sale | Chief Financial Officer | 800 0.0115% | $70.00 | $56,000 | -34.88% | ||
2024-10-17 | Sale | Chief Financial Officer | 10,216 0.1639% | $78.26 | $799,527 | -33.45% | ||
2024-04-22 | 10 percent owner | 17,857 0.205% | $56.00 | $999,992 | -31.30% | |||
2024-04-22 | 10 percent owner | 17,857 0.205% | $56.00 | $999,992 | -31.30% | |||
2024-04-22 | 10 percent owner | 17,857 0.205% | $56.00 | $999,992 | -31.30% | |||
2024-04-22 | 10 percent owner | 17,857 0.205% | $56.00 | $999,992 | -31.30% | |||
2024-04-22 | 10 percent owner | 17,857 0.205% | $56.00 | $999,992 | -31.30% | |||
2024-04-22 | 10 percent owner | 17,857 0.205% | $56.00 | $999,992 | -31.30% | |||
2024-04-22 | 10 percent owner | 17,857 0.205% | $56.00 | $999,992 | -31.30% | |||
2024-04-22 | 10 percent owner | 17,857 0.205% | $56.00 | $999,992 | -31.30% | |||
2024-04-22 | 10 percent owner | 17,857 0.205% | $56.00 | $999,992 | -31.30% | |||
2024-04-22 | 10 percent owner | 17,857 0.205% | $56.00 | $999,992 | -31.30% |